|
|
Volumn 372, Issue 25, 2015, Pages 2463-
|
|
The authors reply
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
PLACEBO;
ANTIVIRUS AGENT;
GANCICLOVIR;
AREA UNDER THE CURVE;
AUDIOLOGY;
CHILD;
CHILD CARE;
CONGENITAL DISORDER;
CYTOMEGALOVIRUS INFECTION;
HEARING;
HUMAN;
INTRAUTERINE GROWTH RETARDATION;
LETTER;
MEDICAL INFORMATION;
PERCEPTION DEAFNESS;
PREDICTION;
PRIORITY JOURNAL;
RISK FACTOR;
SYMPTOMATOLOGY;
THROMBOCYTE COUNT;
TREATMENT DURATION;
TREATMENT OUTCOME;
VIRUS LOAD;
ANALOGS AND DERIVATIVES;
CYTOMEGALOVIRUS INFECTIONS;
HEARING LOSS, SENSORINEURAL;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS INFECTIONS;
GANCICLOVIR;
HEARING LOSS, SENSORINEURAL;
HUMANS;
|
|
EID: 84931453753
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1504937 Document Type: Letter |
|
Times cited : (16)
|
|
References (7)
|
